#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiac failure acute Leiomyosarcoma PIK3CA-activated mutation Progressive familial intrahepatic cholestasis Leukoencephalopathy HER2 gene amplification T-cell type acute leukaemia Myotonic dystrophy Bronchopulmonary dysplasia Anal squamous cell carcinoma Aspergillus infection Retinitis pigmentosa Pulmonary hypertension Thrombocytopenia Breast cancer More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Diagnostics Netherton’s syndrome IgA nephropathy – Trials in Disease Familial amyotrophic lateral sclerosis – Trials in Disease Uterine leiomyosarcoma – Life with Disease Hereditary ataxia – Trials in Disease Systemic sclerosis pulmonary – Trials in Disease Antithrombin III deficiency – Trials in Disease Osteosarcoma recurrent – Life with Disease Angelman’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Retinol Acetate F125/10 Etravirine Specific Nucleic Acid Sna-Xfsa Human Coagulation Factor Ii Propofol SILYMARIN Vgl101 Montelukast SAR444336 Mexiletine Hydrochloride Sotatercept VG801-2 Cx-037231 A52 GSKVX000000048111 Follitropin Alfa Rbl035.2 Tanimilast Hyoscine More therapies…

    Learn about Your Condition

    Skin neoplasm excision Rasmussen encephalitis Chondroplasty Diabetic neuropathy Anaplastic thyroid cancer Cardiac failure congestive Infertility female Aortic disorder Metabolic disorder Staphylococcal infection Krabbe's disease Alcoholism Endometrial adenocarcinoma Stress urinary incontinence Metastasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • A study to evaluate the safety and effectiveness of ADX-038 in adults with geographic atrophy caused by age-related macular degeneration.

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Sodium Chloride
    • ADX-038
    Germany Italy Portugal Spain

  • Study to evaluate the effect of upadacitinib on the frequency of eye inflammation in patients with axial spondyloarthritis.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Upadacitinib
    Bulgaria France Germany The Netherlands Poland Spain

  • A study to evaluate the effectiveness of nicotinamide in patients with Leber’s hereditary optic neuropathy who have experienced vision loss within the last 18 months

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hereditary optic atrophy
    Investigated Drugs:
    • Nicotinamide
    France

  • A study testing teprotumumab compared to placebo in adult patients with moderate-to-severe active thyroid eye disease

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Teprotumumab
    France Germany Italy Poland Spain

  • Treatment of Severe Eye Chemical Burns with Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Patients with Severe Ocular Chemical Burns

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Povidone, Iodinated
    • Remifentanil Hydrochloride
    • Human Serum Albumin
    France

  • A study to test if atorvastatin can prevent eye disease in patients newly diagnosed with Graves’ disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Graves’ disease
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Atorvastatin
    Sweden
Previous Page
1 … 12 13 14 15 16 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!